Concurrent Investment Advisors LLC Has $4.20 Million Holdings in Aflac Incorporated $AFL

Concurrent Investment Advisors LLC grew its position in shares of Aflac Incorporated (NYSE:AFL) by 3.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 39,847 shares of the financial services provider’s stock after buying an additional 1,438 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Aflac were worth $4,202,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also made changes to their positions in AFL. AlphaCore Capital LLC bought a new position in Aflac in the 1st quarter worth approximately $28,000. Hilltop National Bank bought a new stake in shares of Aflac during the second quarter valued at approximately $32,000. Golden State Wealth Management LLC boosted its stake in Aflac by 121.9% in the 1st quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider’s stock valued at $34,000 after buying an additional 167 shares in the last quarter. Groupe la Francaise acquired a new stake in Aflac in the 1st quarter valued at $34,000. Finally, Garde Capital Inc. acquired a new stake in Aflac in the 1st quarter valued at $36,000. 67.44% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. JPMorgan Chase & Co. boosted their price objective on Aflac from $96.00 to $100.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 8th. Keefe, Bruyette & Woods upped their price objective on Aflac from $108.00 to $110.00 and gave the company a “market perform” rating in a report on Thursday, October 9th. UBS Group lowered their price target on Aflac from $114.00 to $111.00 and set a “neutral” rating for the company in a report on Wednesday, August 6th. Morgan Stanley upped their price objective on Aflac from $108.00 to $113.00 and gave the stock an “equal weight” rating in a research report on Monday, August 18th. Finally, Barclays reissued an “underweight” rating and set a $102.00 price target (up from $100.00) on shares of Aflac in a research report on Wednesday, October 8th. Three equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $109.45.

Aflac Trading Down 0.7%

Shares of AFL opened at $110.21 on Tuesday. Aflac Incorporated has a 52-week low of $96.95 and a 52-week high of $115.44. The business’s fifty day moving average is $107.78 and its 200-day moving average is $105.45. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.11 and a current ratio of 0.11. The firm has a market cap of $58.94 billion, a price-to-earnings ratio of 24.99, a PEG ratio of 3.08 and a beta of 0.86.

Aflac (NYSE:AFL) last released its quarterly earnings data on Monday, February 27th. The financial services provider reported $1.07 earnings per share for the quarter. The company had revenue of $5.91 billion for the quarter. Aflac had a return on equity of 15.08% and a net margin of 15.32%. Equities analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 2nd. Investors of record on Wednesday, August 20th were given a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend was Wednesday, August 20th. Aflac’s payout ratio is presently 52.61%.

Aflac declared that its board has initiated a stock repurchase plan on Tuesday, August 12th that allows the company to repurchase 100,000,000 shares. This repurchase authorization allows the financial services provider to repurchase shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

Insider Buying and Selling

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $102.57, for a total value of $102,570.00. Following the completion of the sale, the director directly owned 25,105 shares of the company’s stock, valued at $2,575,019.85. The trade was a 3.83% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.80% of the stock is owned by insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.